Bhide SA - Search Results

1

Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma.

Nutting CM, van Herpen CM, Miah AB, Bhide SA, Machiels JP, Buter J, Kelly C, de Raucourt D, Harrington KJ. Nutting CM, et al. Among authors: bhide sa. Ann Oncol. 2009 Jul;20(7):1275-9. doi: 10.1093/annonc/mdn775. Epub 2009 Feb 26. Ann Oncol. 2009. PMID: 19246715 Free article. Clinical Trial.

2

Otological toxicity after postoperative radiotherapy for parotid tumours.

Bhide SA, Harrington KJ, Nutting CM. Bhide SA, et al. Clin Oncol (R Coll Radiol). 2007 Feb;19(1):77-82. doi: 10.1016/j.clon.2006.11.007. Clin Oncol (R Coll Radiol). 2007. PMID: 17305258 Review.

3

Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo.

White CL, Menghistu T, Twigger KR, Searle PF, Bhide SA, Vile RG, Melcher AA, Pandha HS, Harrington KJ. White CL, et al. Among authors: bhide sa. Gene Ther. 2008 Mar;15(6):424-33. doi: 10.1038/sj.gt.3303081. Epub 2007 Dec 13. Gene Ther. 2008. PMID: 18079753

4

Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer.

Bhide SA, Ahmed M, Barbachano Y, Newbold K, Harrington KJ, Nutting CM. Bhide SA, et al. Br J Cancer. 2008 Jul 8;99(1):57-62. doi: 10.1038/sj.bjc.6604444. Epub 2008 Jun 17. Br J Cancer. 2008. PMID: 18560402 Free PMC article.

5

Radical radiotherapy for treatment of malignant parotid tumours: a single centre experience 1995-2005.

Bhide SA, Miah A, Barbachano Y, Harrington KJ, Newbold K, Nutting CM. Bhide SA, et al. Br J Oral Maxillofac Surg. 2009 Jun;47(4):284-9. doi: 10.1016/j.bjoms.2008.12.012. Epub 2009 Feb 4. Br J Oral Maxillofac Surg. 2009. PMID: 19193477

6

Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer.

Clark CH, Miles EA, Urbano MT, Bhide SA, Bidmead AM, Harrington KJ, Nutting CM; UK PARSPORT Trial Management Group collaborators. Clark CH, et al. Among authors: bhide sa. Br J Radiol. 2009 Jul;82(979):585-94. doi: 10.1259/bjr/31966505. Epub 2009 Mar 30. Br J Radiol. 2009. PMID: 19332518 Clinical Trial.

7

Dosimetry audit for a multi-centre IMRT head and neck trial.

Clark CH, Hansen VN, Chantler H, Edwards C, James HV, Webster G, Miles EA, Guerrero Urbano MT, Bhide SA, Bidmead AM, Nutting CM; PARSPORT Trial Management Group. Clark CH, et al. Among authors: bhide sa. Radiother Oncol. 2009 Oct;93(1):102-8. doi: 10.1016/j.radonc.2009.04.025. Radiother Oncol. 2009. PMID: 19596158 Clinical Trial.

8

Radiation-induced xerostomia: pathophysiology, prevention and treatment.

Bhide SA, Miah AB, Harrington KJ, Newbold KL, Nutting CM. Bhide SA, et al. Clin Oncol (R Coll Radiol). 2009 Dec;21(10):737-44. doi: 10.1016/j.clon.2009.09.002. Epub 2009 Oct 14. Clin Oncol (R Coll Radiol). 2009. PMID: 19833490 Review.

9

Advances in chemotherapy for head and neck cancer.

Bhide SA, Nutting CM. Bhide SA, et al. Oral Oncol. 2010 Jun;46(6):436-8. doi: 10.1016/j.oraloncology.2010.03.004. Epub 2010 Apr 18. Oral Oncol. 2010. PMID: 20400360 Review.

10

Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers.

Powell C, Mikropoulos C, Kaye SB, Nutting CM, Bhide SA, Newbold K, Harrington KJ. Powell C, et al. Among authors: bhide sa. Cancer Treat Rev. 2010 Nov;36(7):566-75. doi: 10.1016/j.ctrv.2010.03.003. Epub 2010 Apr 20. Cancer Treat Rev. 2010. PMID: 20409643 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page